Ferring announces recipients of 2018-19 Innovation Grants
- by pulseFerring Pharmaceuticals today announced the recipients of the 2018-19 Ferring Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in San Diego.
pulse
Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer
- by pulseFerring Pharmaceuticals today announced that Michel Pettigrew, President of the Executive Board and Chief Operating Officer…
pulse
Ferring Pharmaceuticals and Evotec AG form strategic research alliance in reproductive medicine and women’s health
- by pulseFerring Pharmaceuticals and Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced a strategic research alliance…
pulse
Ferring and Celmatix launch ambitious genomics collaboration to advance care in reproductive medicine and women’s health
- by pulseFerring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian…
pulse
New analysis of Rekovelle® data further supports use of AMH to personalise fertility treatment
- by pulseFerring Pharmaceuticals announced today a new analysis* of data from the Phase 3 ESTHER-1 trial…
pulse